Axxess Pharma Inc. Receives Signed Term Sheet From TCA Global Credit Master Fund to Secure US $4 Million Revolving Line of Cr...
October 30 2013 - 7:00AM
Marketwired
Axxess Pharma Inc. Receives Signed Term Sheet From TCA Global
Credit Master Fund to Secure US $4 Million Revolving Line of Credit
Line of Credit to Fund Worldwide Product Expansion and Generate
Significant Revenue in Near-Term
TORONTO, ON--(Marketwired - Oct 30, 2013) - Axxess Pharma Inc.
(PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional
supplements company is pleased to announce they have received a
signed term sheet from TCA Global Credit Masters Fund (TCA) to
secure a US $4 million revolving line of credit. Closing is
anticipated within 14 days, pending final due diligence from Axxess
Pharma Inc. and TCA. The revolving line of credit will enable
Axxess Pharma to generate significant revenue in the near-term with
high gross profit margins.
This is expected to be the beginning of a long-term partnership
between TCA Global and Axxess Pharma which will assist Axxess
Pharma's capital needs as sales continue to grow. The line of
credit will be used to aggressively develop, market and sell its
line of pain relief and muscle recovery products worldwide, as well
as develop and market a vitamins and minerals line under the TapouT
brand name. Management will also release a second wave of TapouT
branded products which will be a premium vitamins line.
"This is an exciting time for our company. The $4 million
revolving line of credit with TCA will allow our company to expand
worldwide, fulfil current orders and quickly become a multi-million
dollar revenue generating company," said Dr. Bagi, President of
Axxess Pharma Inc." Dr. Bagi further stated, "In addition to our
current TapouT products, we have additional products in the
pipeline for release in 2014."
About TCA Fund Management Group:
TCA Fund Management Group (www.trafcap.com) as the Investment
Manager for TCA Global Credit Master Fund L.P. acts as an advisor
to many small companies from its offices in the United States,
United Kingdom, and Australia. TCA is a short duration, absolute
return fund specializing in senior-secured lending to small, mainly
listed companies in the U.S., Canada, Western Europe, and
Australia. The team has a level of domestic and cross-border
expertise, long-standing experience with funding innovations, as is
reflected in the number of transactions completed. This is a
specialist business with an investment approach that fills an
important finance gap in many leading markets. TCA provides a
unique conduit for investors seeking uncorrelated returns in the
small cap debt universe.
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its
wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc.,
headquartered in Toronto. Axxess is a specialty Health Care
Products Company dedicated to improving health and quality of life
by offering select medicines, nutritional supplements and over the
counter remedies all across the Americas. Axxess's goal is to bring
additional products to the market and provide new, innovative
options for better health spanning areas such as high cholesterol,
blood pressure, acute pain, to optimal health management through
improved nutritional supplements.
For more information, please visit www.axxesspharmainc.com, or
contact Investor Relations at (973) 351-3868.
Safe Harbor Statement
Statements about the Company's future expectations and all other
statements in this press release other than historical facts, are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities
Litigation Reform Act of 1995. The Company intends that such
forward-looking statements be subject to the safe harbors created
thereby.
The above information contains information relating to the
Company that is based on the beliefs of the Company and/or its
management, as well as assumptions made by any information
currently available to the Company or its management. When used in
this document, the words "anticipate," "estimate," "expect,"
"intend," "plans," "projects," and similar expressions, as they
relate to the Company or its management, are intended to identify
forward-looking statements. Such statements reflect the current
view of the Company regarding future events and are subject to
certain risks, uncertainties and assumptions, including the risks
and uncertainties noted. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
to be incorrect, actual results may vary materially from those
described herein as anticipated, believed, estimated, expected,
intended or projected. In each instance, forward-looking
information should be considered in light of the accompanying
meaningful cautionary statements herein. Factors that could cause
results to differ include, but are not limited to, successful
performance of internal plans, the impact of competitive services
and pricing and general economic risks and uncertainties.
Contact: Investor Relations Taylor Capitol, Inc. Stephen Taylor
(973) 351-3868 STEPHTAYL9@AOL.COM www.TheStockAlerts.com
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Oct 2024 to Nov 2024
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Nov 2023 to Nov 2024
